Scan barcode
![Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation by Michael D. Green](https://558130.bdp32.group/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFZ1NEE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--eb07c7b9d87d71ed861527800a843cde670b07f4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFJc0FXa0M5QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--038335c90cf75c275ae4d36968ac417dc4a0a3e3/Bendectin%20and%20Birth%20Defects-%20The%20Challenges%20of%20Mass%20Toxic%20Substances%20Litigation.jpg)
384 pages • missing pub info (editions)
ISBN/UID: 9780812216455
Format: Paperback
Language: English
Publisher: University of Pennsylvania Press
Publication date: 01 January 1998
Description
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, join...
Community Reviews
Content Warnings
![Bendectin and Birth Defects: The Challenges of Mass Toxic Substances Litigation by Michael D. Green](https://558130.bdp32.group/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeFZ1NEE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--eb07c7b9d87d71ed861527800a843cde670b07f4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCem9MWm05eWJXRjBTU0lJYW5CbkJqb0dSVlE2RkhKbGMybDZaVjkwYjE5c2FXMXBkRnNIYVFJc0FXa0M5QUU9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--038335c90cf75c275ae4d36968ac417dc4a0a3e3/Bendectin%20and%20Birth%20Defects-%20The%20Challenges%20of%20Mass%20Toxic%20Substances%20Litigation.jpg)
384 pages • missing pub info (editions)
ISBN/UID: 9780812216455
Format: Paperback
Language: English
Publisher: University of Pennsylvania Press
Publication date: 01 January 1998
Description
Benedictin was prescribed to more than thirty-five million American women from its introduction in 1956 until 1983, when it was withdrawn from the market. The drug's manufacturer, Merrill Dow Pharmaceuticals, a major U.S. pharmaceutical firm, join...